- Home
- SGMO vs STKS Comparison
SGMO vs STKS Comparison
Compare SGMO & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- STKS
- Stock Information
- Founded
- SGMO 1995
- STKS 2004
- Country
- SGMO United States
- STKS United States
- Employees
- SGMO N/A
- STKS N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- STKS Restaurants
- Sector
- SGMO Health Care
- STKS Consumer Discretionary
- Exchange
- SGMO Nasdaq
- STKS Nasdaq
- Market Cap
- SGMO 122.8M
- STKS 112.2M
- IPO Year
- SGMO 2000
- STKS N/A
- Fundamental
- Price
- SGMO $0.46
- STKS $3.43
- Analyst Decision
- SGMO Buy
- STKS Buy
- Analyst Count
- SGMO 6
- STKS 2
- Target Price
- SGMO $4.50
- STKS $4.25
- AVG Volume (30 Days)
- SGMO 4.1M
- STKS 60.1K
- Earning Date
- SGMO 08-05-2025
- STKS 08-05-2025
- Dividend Yield
- SGMO N/A
- STKS N/A
- EPS Growth
- SGMO N/A
- STKS N/A
- EPS
- SGMO N/A
- STKS N/A
- Revenue
- SGMO $63,756,000.00
- STKS $799,478,000.00
- Revenue This Year
- SGMO N/A
- STKS $28.67
- Revenue Next Year
- SGMO N/A
- STKS $5.12
- P/E Ratio
- SGMO N/A
- STKS N/A
- Revenue Growth
- SGMO 239.92
- STKS 138.50
- 52 Week Low
- SGMO $0.30
- STKS $2.37
- 52 Week High
- SGMO $3.18
- STKS $5.42
- Technical
- Relative Strength Index (RSI)
- SGMO 38.27
- STKS 46.52
- Support Level
- SGMO $0.49
- STKS $3.35
- Resistance Level
- SGMO $0.51
- STKS $3.80
- Average True Range (ATR)
- SGMO 0.04
- STKS 0.29
- MACD
- SGMO 0.01
- STKS -0.04
- Stochastic Oscillator
- SGMO 6.25
- STKS 34.57
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.